Kolexia
Levy Eric Oncologie radiothérapie
Levy Eric
Oncologie radiothérapie
Cabinet libéral
Paris, France
49 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Récidive tumorale locale Carcinome canalaire du sein Coma Cardiopathies Maladie de Lyme Carcinome intracanalaire non infiltrant Carcinome lobulaire

Collaborateurs

Voir plus
Chauveinc Laurent
Chauveinc Laurent
Cmc Ambroise Pare Hartmann Site 48 Ter, Neuilly-sur-Seine, France
Lansiaux Patrick
Lansiaux Patrick
Clinique Bizet, Paris, France
Eiss David
Eiss David
Hôpital Necker Enfants Malades, Paris, France
Evrard Paul-Louis
Evrard Paul-Louis
Clinique De L Alma, Paris, France

Industries

Voir plus
Ipsen
5 collaboration(s)
Dernière en 2023
Lilly
5 collaboration(s)
Dernière en 2023
AstraZeneca
4 collaboration(s)
Dernière en 2023
Vifor
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis.
Annals of surgical oncology   28 mars 2021
Dr Thomas E Levy - Mega Dose Vitamin C expert shares his wisdom on reversing cancer and all disease.
Youtube @ Health Awareness Vitality Abundance   19 décembre 2020
Long-term Results After Oncoplastic Surgery for Breast Cancer: A 10-year Follow-up.
Annals of surgery   03 septembre 2019
Breast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients.
Breast cancer research and treatment   11 mai 2013
Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.
Drugs in R&D   16 avril 2012
Myotax: a phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
European journal of cancer (Oxford, England : 1990)   13 septembre 2011
Effect of neoadjuvant alternating taxane- and anthracycline-based dose-dense regimen for operable breast cancer on prognosis in triple-negative tumors with a complete histological response.
2010 ASCO Annual Meeting I   20 mai 2010
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}